Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony- stimulating factor

Journal of Clinical Oncology

Volumn 15, Issue 2, 1997, Pages 684-690

  Demirer, T ^a   Buckner, C D ^a   Storer, B ^a   Lilleby, K ^a   Rowley, S ^a   Clift, R ^a   Appelbaum, F R ^a   Storb, R ^a   Bensinger, W I ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL;

ADULT; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; MAJOR CLINICAL STUDY; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031033629     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.2.684     Document Type: Article

References (29)

1. Bensinger WI, Longin K, Appelbaum F, et al.: Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): An analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 87:825-831, 1994
2. Bensinger WI, Appelbaum FR, Rowley S, et al.: Factors that influence collection and engraftment of autologous peripheral-blood stem cells. J Clin Oncol 13:2547-2555, 1995
3. Tricot G, Jagannath S, Vesole D, et al.: Peripheral blood stem cell transplants for multiple myeloma: Identification of favorable variables for rapid engraftment in 225 patients. Blood 85:588-596, 1995
4. Weaver CH, Hazelton B, Birch R, et al.: An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy. Blood 86:3961-3969, 1996
5. Demirer T, Buckner CD, Gooley T, et al.: Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma. Bone Marrow Transplant 17:937-941, 1996
6. Haas R, Möhle R, Frühauf S, et al.: Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 83:3787-3794, 1994
7. Kotasek D, Shepherd KM, Sage RE, et al.: Factors affecting blood stem cell collections following high-dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 9:11-17, 1992
8. Demirer T, Buckner CD, Bensinger WI et al.: Peripheral blood stem cell (PBSC) collections after Taxol, cyclophosphamide and recombinant human granulocyte-colony stimulating factor (rhG-CSF). J Clin Oncol 13:1714-1719, 1995
9. Demirer T, Buckner CD, Lilleby K, et al.: Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed disease. Cancer 74:715-721, 1994
10. Schwartzberg LS, Birch R, Hazelton B, et al.: Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte-colony stimulating factor. J Hematother 1:317-327, 1992
11. Bensinger W, Singer J, Appelbaum F, et al.: Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81:3158-3163, 1993
12. Demirer T, Buckner CD, Appelbaum FR et al.: Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. Bone Marrow Transplant 15:915-922, 1995
13. Passos-Coelho JL, Braine HG, Davis JM, et al.: Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization. J Clin Oncol 13:705-714, 1995
14. Brugger W, Bross K, Frisch J, et al.: Mobilization of peripheral blood progenitor cells by sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following polychemotherapy with etoposide, ifosfamide, and cisplatin. Blood 79:1193-1200, 1992
15. + peripheral blood progenitor cells (PBPC) in patients with responding metastatic breast cancer undergoing high dose chemotherapy. Proc Am Soc Clin Oncol 14:313, 1995 (abstr 919)
16. To LB, Shepperd M, Haylock DN, et al.: Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells from the peripheral blood. Exp Hematol 18:442-447, 1990
17. Hohaus S, Goldschmidt H, Ehrhardt R, et al.: Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF. Exp Hematol 21:508-514, 1993
18. Sica S, Dimario A, Salutari P, et al.: Sequential peripheral blood progenitor cell transplantation after mobilization with salvage chemotherapy and G-CSF in patients with resistant lymphoma. Am J Hematol 46:18-23, 1994
19. Nademanee A, Sniecinski I, Schmidt GM, et al.: High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells. J Clin Oncol 12:2176-2186, 1994
20. Sheridan W, Begley G, Juttner C, et al.: Effect of different doses and schedules of filgrastim on mononuclear cell and PBPC collections and hematopoietic recovery after high dose chemotherapy and infusion of filgrastim mobilized PBPC without bone marrow. Proc Am Soc Hematol 80:331a, 1992 (abstr 1315)
21. + cells. Blood 84:413a, 1994 (suppl 1, abstr 413)
22. Demirer T, Buckner CD, Bensinger WI: Optimization of peripheral blood stem cell mobilization. Stem Cells 14:106-116, 1996
23. 8/kg is sufficient to predict early multilineage engraftment in patients undergoing high dose therapy and transplantation with cryopreserved peripheral blood progenitor cells for malignant lymphoma. Blood 84:94a, 1994 (suppl 1, abstr 364)
24. Elias AD, Ayash L, Anderson KC, et al.: Mobilization of peripheral blood progenitor cells by chemotherapy and granulocytemacrophage colony-stimulating factor for hematologic support after high-dose intensification for breast cancer. Blood 79:3036-3044, 1992
25. Pettengell R, Morgenstern GR, Woll PJ, et al.: Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 2:3770-3777, 1993
26. Ho AD, Gluck S, Germond C, et al.: Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer. Leukemia 7:1738-1744, 1993
27. Dreger P, Marquardt P, Haferlach T, et al.: Effective mobilization of peripheral blood progenitor cells with Dexa-BEAM and G-CSF-timing of harvesting and composition of the leukapheresis product. Br J Cancer 68:5:950-957, 1993
28. Siena S, Bregni M, Brando B, et al.: Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400-409, 1991
29. Bender JG, Williams SF, Myers S, et al.: Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation. Bone Marrow Transplant 10:281-285, 1992